Amicus Therapeutics Stock Price History

FOLD Stock  USD 9.49  0.30  3.26%   
Below is the normalized historical share price chart for Amicus Therapeutics extending back to May 31, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Amicus Therapeutics stands at 9.49, as last reported on the 1st of March, with the highest price reaching 9.50 and the lowest price hitting 9.14 during the day.
IPO Date
31st of May 2007
200 Day MA
10.2881
50 Day MA
9.5216
Beta
0.607
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Amicus Stock, it is important to understand the factors that can impact its price. Amicus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.03, which signifies that the company had a -0.03 % return per unit of risk over the last 3 months. Amicus Therapeutics exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amicus Therapeutics' Risk Adjusted Performance of 0.0128, downside deviation of 2.39, and Mean Deviation of 1.3 to double-check the risk estimate we provide.
  
At present, Amicus Therapeutics' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 3.1 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 491.9 M. . At present, Amicus Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 15.52, whereas Price Earnings Ratio is projected to grow to (48.55). Amicus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.03

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsFOLD

Estimated Market Risk

 2.01
  actual daily
17
83% of assets are more volatile

Expected Return

 -0.06
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Amicus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amicus Therapeutics by adding Amicus Therapeutics to a well-diversified portfolio.
Price Book
14.5509
Enterprise Value Ebitda
102.6654
Price Sales
5.5191
Shares Float
249.7 M
Wall Street Target Price
16.7273

Amicus Therapeutics Stock Price History Chart

There are several ways to analyze Amicus Stock price data. The simplest method is using a basic Amicus candlestick price chart, which shows Amicus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 11, 202410.16
Lowest PriceJanuary 10, 20259.02

Amicus Therapeutics March 1, 2025 Stock Price Synopsis

Various analyses of Amicus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Amicus Stock. It can be used to describe the percentage change in the price of Amicus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Amicus Stock.
Amicus Therapeutics Price Action Indicator 0.32 
Amicus Therapeutics Accumulation Distribution 115,084 
Amicus Therapeutics Price Daily Balance Of Power 0.83 
Amicus Therapeutics Price Rate Of Daily Change 1.03 

Amicus Therapeutics March 1, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Amicus Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Amicus Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Amicus Stock and then apply it to test your longer-term investment strategies against Amicus.

Amicus Stock Price History Data

The price series of Amicus Therapeutics for the period between Sun, Dec 1, 2024 and Sat, Mar 1, 2025 has a statistical range of 1.14 with a coefficient of variation of 2.8. Under current investment horizon, the daily prices are spread out with arithmetic mean of 9.6. The median price for the last 90 days is 9.64. The company completed dividends distribution on 2009-08-31.
OpenHighLowCloseVolume
02/28/2025 9.22  9.50  9.14  9.49  3,036,949 
02/27/2025 9.00  9.42  8.92  9.19  2,374,716 
02/26/2025 9.07  9.18  9.00  9.03  1,567,224 
02/25/2025 9.42  9.55  9.09  9.11  2,307,272 
02/24/2025 9.16  9.56  9.00  9.34  3,730,640 
02/21/2025 9.15  9.26  9.02  9.19  2,603,411 
02/20/2025 9.42  9.64  9.06  9.07  3,321,922 
02/19/2025 9.11  10.00  9.07  9.56  4,437,979 
02/18/2025 9.73  9.94  9.68  9.85  2,490,153 
02/14/2025 9.68  9.82  9.65  9.77  1,944,625 
02/13/2025 9.63  9.72  9.49  9.64  1,782,509 
02/12/2025 9.38  9.59  9.35  9.55  2,927,962 
02/11/2025 9.54  9.65  9.32  9.57  2,918,602 
02/10/2025 9.69  9.73  9.47  9.64  2,110,970 
02/07/2025 9.84  9.84  9.50  9.65  2,826,031 
02/06/2025 9.78  9.91  9.68  9.83  2,385,274 
02/05/2025 9.80  9.95  9.66  9.78  1,843,664 
02/04/2025 9.62  9.85  9.61  9.76  1,311,567 
02/03/2025 9.44  9.68  9.39  9.64  1,503,915 
01/31/2025 9.62  9.73  9.56  9.58  1,743,009 
01/30/2025 9.63  9.80  9.53  9.64  1,627,045 
01/29/2025 9.60  9.72  9.47  9.59  1,683,979 
01/28/2025 9.66  9.81  9.60  9.66  1,964,198 
01/27/2025 9.61  9.83  9.57  9.68  1,831,330 
01/24/2025 9.60  9.74  9.43  9.61  1,887,373 
01/23/2025 9.45  9.73  9.41  9.65  1,864,692 
01/22/2025 9.50  9.61  9.47  9.54  1,635,456 
01/21/2025 9.50  9.63  9.40  9.51  1,774,523 
01/17/2025 9.46  9.46  9.21  9.41  1,610,164 
01/16/2025 9.26  9.47  9.19  9.36  2,265,083 
01/15/2025 9.35  9.41  9.12  9.27  2,504,613 
01/14/2025 9.20  9.39  9.10  9.21  4,134,129 
01/13/2025 9.44  9.44  8.79  9.23  3,587,088 
01/10/2025 9.34  9.34  8.85  9.02  3,244,248 
01/08/2025 9.37  9.54  9.15  9.46  2,820,828 
01/07/2025 9.33  9.54  9.29  9.36  1,600,118 
01/06/2025 9.41  9.49  9.28  9.30  1,636,312 
01/03/2025 9.32  9.52  9.27  9.41  1,692,753 
01/02/2025 9.48  9.57  9.29  9.31  2,349,968 
12/31/2024 9.45  9.49  9.35  9.42  1,363,978 
12/30/2024 9.57  9.57  9.32  9.41  1,224,902 
12/27/2024 9.69  9.79  9.55  9.63  1,651,179 
12/26/2024 9.73  9.84  9.65  9.77  1,130,720 
12/24/2024 9.81  9.86  9.62  9.79  921,056 
12/23/2024 9.73  9.84  9.66  9.84  1,464,014 
12/20/2024 9.68  9.88  9.60  9.80  4,077,528 
12/19/2024 9.58  9.87  9.44  9.73  2,616,135 
12/18/2024 9.87  9.93  9.41  9.57  2,616,218 
12/17/2024 9.86  9.97  9.72  9.89  1,946,241 
12/16/2024 9.37  9.99  9.28  9.90  3,495,587 
12/13/2024 9.85  9.91  9.30  9.36  4,100,547 
12/12/2024 10.06  10.20  10.02  10.15  2,156,761 
12/11/2024 10.14  10.36  10.09  10.16  1,937,488 
12/10/2024 9.87  10.20  9.82  10.13  3,000,240 
12/09/2024 9.76  10.00  9.74  9.83  7,813,576 
12/06/2024 9.82  9.97  9.57  9.73  6,562,299 
12/05/2024 9.80  9.89  9.72  9.76  1,730,897 
12/04/2024 9.80  9.99  9.75  9.86  1,685,215 
12/03/2024 9.90  9.99  9.72  9.79  2,068,442 
12/02/2024 9.96  10.15  9.92  9.96  1,997,520 
11/29/2024 9.96  10.03  9.93  9.98  818,677 

About Amicus Therapeutics Stock history

Amicus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amicus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amicus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amicus Therapeutics stock prices may prove useful in developing a viable investing in Amicus Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding304.4 M319.6 M
Net Loss-212.9 M-223.6 M

Amicus Therapeutics Quarterly Net Working Capital

356.03 Million

Amicus Therapeutics Stock Technical Analysis

Amicus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Amicus Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Amicus Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Amicus Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Amicus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Amicus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amicus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Amicus Stock analysis

When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
CEOs Directory
Screen CEOs from public companies around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities